Clinical Outcomes Following Radical Cystectomy for Primary Nontransitional Cell Carcinoma of the Bladder Compared to Transitional Cell Carcinoma of the Bladder-Reference-Cited by-同舟云学术

Clinical Outcomes Following Radical Cystectomy for Primary Nontransitional Cell Carcinoma of the Bladder Compared to Transitional Cell Carcinoma of the Bladder

Published:2006-06 Issue:6 Volume:175 Page:2048-2053
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Rogers Craig G.¹,Palapattu Ganesh S.¹,Shariat Shahrokh F.²,Karakiewicz Pierre I.³,Bastian Patrick J.¹,Lotan Yair²,Gupta Amit²,Vazina Amnon⁴,Gilad Amiel⁴,Sagalowsky Arthur I.²,Lerner Seth P.⁴,Schoenberg Mark P.¹

Affiliation:

1. Bladder Cancer Research Consortium, James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland

2. Department of Urology, University of Texas Southwestern Medical School, Dallas

3. Texas, and Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada

4. Scott Department of Urology, Baylor College of Medicine, Houston

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Cancer Incidence in Five Continents;Parkin,2003

2. Squamous carcinoma of the bladder;Richie;J Urol,1976

3. Radical cystectomy for carcinoma of the bladder;Ghoneim;J Urol,1997

4. Primary adenocarcinoma of the bladder;Jacobo;J Urol,1977

5. Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases;Trias;Eur Urol,2001

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid Bladder Tumor: Urothelial Carcinoma With Squamous Cell Differentiation, Urothelial Sarcomatoid Carcinoma, and Concurrent Primary Mucinous Adenocarcinoma With Metastasis to the Penis;Cureus;2024-09-07

2. Current Advances in the Management of Nonurothelial Subtypes of Bladder Cancer;American Society of Clinical Oncology Educational Book;2024-06

3. Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan;Journal of Cancer Research and Clinical Oncology;2024-04-09

4. Survival Outcomes of Treatment Modalities in Patients with Variant Histopathology of Bladder Cancer in First Transurethral Resection of the Bladder;The Bulletin of Urooncology;2024-04-04

5. Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study;Biomolecules and Biomedicine;2023-11-30